0001415889-24-016967.txt : 20240614
0001415889-24-016967.hdr.sgml : 20240614
20240614170013
ACCESSION NUMBER: 0001415889-24-016967
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240612
FILED AS OF DATE: 20240614
DATE AS OF CHANGE: 20240614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FAIRBAIRN EMILY
CENTRAL INDEX KEY: 0001682638
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39692
FILM NUMBER: 241045742
MAIL ADDRESS:
STREET 1: 10 ORINDA VIEW ROAD
CITY: ORINDA
STATE: CA
ZIP: 94563
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IN8BIO, INC.
CENTRAL INDEX KEY: 0001740279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 825462585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: EMPIRE STATE BUILDING
STREET 2: 350 5TH AVENUE, SUITE 5330
CITY: NEW YORK
STATE: NY
ZIP: 10118
BUSINESS PHONE: (646) 600-6438
MAIL ADDRESS:
STREET 1: EMPIRE STATE BUILDING
STREET 2: 350 5TH AVENUE, SUITE 5330
CITY: NEW YORK
STATE: NY
ZIP: 10118
FORMER COMPANY:
FORMER CONFORMED NAME: Incysus Therapeutics, Inc.
DATE OF NAME CHANGE: 20180510
4
1
form4-06142024_050610.xml
X0508
4
2024-06-12
0001740279
IN8BIO, INC.
INAB
0001682638
FAIRBAIRN EMILY
C/O IN8BIO, INC.
350 5TH AVENUE, SUITE 5330
NEW YORK
NY
10118
true
false
false
false
0
Stock Option (right to buy)
1.47
2024-06-12
4
A
0
33650
0
A
2034-06-12
Common Stock
33650
33650
D
One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 12, 2024; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to
the Reporting Person continuing to provide service through each such date.
/s/ Jason Minio, Attorney-in-Fact
2024-06-14